HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,025,184 | -6.3% | 69,368 | -16.7% | 0.03% | 0.0% |
| Q2 2023 | $8,566,994 | -47.4% | 83,296 | -44.2% | 0.03% | -52.8% |
| Q1 2023 | $16,296,676 | -1.8% | 149,319 | +2.4% | 0.07% | -11.1% |
| Q4 2022 | $16,593,406 | +72.8% | 145,812 | -6.0% | 0.08% | +62.0% |
| Q3 2022 | $9,600,000 | +4449.8% | 155,116 | +7941.3% | 0.05% | +4900.0% |
| Q3 2021 | $211,000 | -58.1% | 1,929 | -64.7% | 0.00% | -50.0% |
| Q1 2021 | $503,000 | -91.6% | 5,466 | -93.3% | 0.00% | -92.3% |
| Q4 2020 | $6,003,000 | +12.4% | 82,070 | +19.4% | 0.03% | +4.0% |
| Q3 2020 | $5,341,000 | +87.7% | 68,751 | +34.3% | 0.02% | +78.6% |
| Q2 2020 | $2,845,000 | +412.6% | 51,182 | +173.3% | 0.01% | +250.0% |
| Q1 2020 | $555,000 | +13.3% | 18,728 | +38.5% | 0.00% | +100.0% |
| Q4 2019 | $490,000 | -47.0% | 13,523 | -60.2% | 0.00% | -60.0% |
| Q3 2019 | $925,000 | -39.9% | 33,958 | -47.0% | 0.01% | -37.5% |
| Q2 2019 | $1,540,000 | – | 64,025 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |